Skip to content

Newsroom

Watch the replay of the Fresenius Medical Care 2024 Annual Press Conference regarding full year earnings for 2023, and access press conference media material.

Order our news

Would you like to be included on our distribution list for our news? We would be happy to provide you with our latest press releases and short news by e-mail. This service is free of charge and may be cancelled at any time.

You can cancel this free service at any time by sending an e-mail to ir(at)freseniusmedicalcare.com, or by calling +49 (0) 6172 - 609 2525.

The information you provide will only be used to answer your query. For more information on how we process your Personal Data please read our privacy policy.

newsletter registration

captcha
| Press release
Fresenius Medical Care enters into favorable settlement agreement with U. S. government with positive earnings impact of approx. EUR 175 million – 2023 earnings outlook raised
Fresenius Medical Care, the world's leading provider of products and services for individuals with renal diseases, resolved a legal dispute with the U.S. government, for accounts receivable in legal dispute, and entered into a final and legally binding settlement agreement today, whereby the company will receive a payment from the U.S. government.
1 2 3 ... 25
Related content

Do you have any questions? Contact us!

Fresenius Medical Care is the world’s leading provider of dialysis products and services. Find out more about the company’s key facts and innovations.